Breathe Well Live Well
|
Scientists find potential way to treat cold-triggered asthma
Reuters In a study published in the journal Science Translational Medicine, the researchers found that a small molecule, or 'cytokine', called IL-25 may play a central role in the effect that viruses causing colds have on people with asthma. According to the … |
View full post on asthma – Google News
GlobalPost |
UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters Xolair is an injectible drug that was originally approved in 2003 to treat moderate to severe asthma in adults and children aged 12 or over whose condition was not controlled by inhaled steroids. The drug is also approved to treat chronic idiopathic … FDA says asthma drug Xolair raises risk of heart, brain problems FDA warns of increased risks of asthma drug Xolair FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events |
View full post on asthma – Google News
|
FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters WASHINGTON (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug … FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events FDA warns of increased risks of asthma drug Xolair Xolair (omalizumab): Drug Safety Communication – Slightly Elevated Risk of … |
View full post on asthma – Google News
Headlines & Global News |
Most asthmatic kids lack health management plans at school
Reuters On the rare occasions when a child has died at school from an acute allergy attack or asthma attack, the children usually did not have a health management plan, or a so-called 504 Plan, on file, said Dr. Ruchi Gupta of the Center for Community Health … Schools are not Prepared to Deal with Children's Food Allergies, Asthma Too many kids with asthma, food allergies lack school emergency plans |
View full post on asthma – Google News
Globes |
Teva finds positive results in advanced trials for asthma drug
Reuters Reslizumab, an investigational antibody, showed statistically significant reductions in the frequency of asthma exacerbations – episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness – compared to patients … Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies Teva reports positive Phase III asthma drug results |
View full post on asthma – Google News
Economic Times |
India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will … Cipla targets US with asthma, HIV drugs |
View full post on asthma – Google News
|
Asthma attack rates similar for black and white kids
Reuters NEW YORK (Reuters Health) – A new analysis of U.S. childhood asthma statistics finds racial differences persist in the proportions of African American and white children who develop asthma, but success in managing the disease is becoming more equal. |
View full post on asthma – Google News
|
Does vitamin D help with asthma? More study needed
Reuters “Given that vitamin D is a relatively benign supplement,” the small improvement in lung function “would be worthwhile if it was confirmed with other improvements in asthma control,” he said, such as fewer symptoms or a reduced need for medication. |
View full post on asthma – Google News
Reuters UK |
AstraZeneca starts final-stage tests on severe asthma drug
Reuters Several firms are racing to develop injectable biotech asthma drugs for patients with severe disease who do not respond well to traditional inhalers, in pursuit of a new market worth a possible $7.5 billion a year. (Reporting by Ben Hirschler, Editing … AstraZeneca Starts Phase III Trial For Asthma Drug Tralokinumab AstraZeneca Starts Late-stage Study Of Tralokinumab – Quick Facts |
View full post on asthma – Google News
Medical Daily |
Scientific review finds asthma drugs suppress child growth
Reuters The first of the two systematic reviews focused on 25 trials involving 8,471 children up to 18 years old with mild to moderate persistent asthma. These trials tested almost all the available inhaled corticosteroids and showed they suppressed growth … Asthma Medications Could Stunt Children's Growth, Up To Half A Centimeter … Asthma drugs suppress growth Asthma inhaler use in children slows growth, research finds |
View full post on asthma – Google News